Abstracts

A population pharmacokinetic model for sertraline in depressive patients during the perinatal period: prediction of infant drug exposure through placenta and human milk

Thursday 16 October, 2025

Introduction/Objectives: Depression affects around 10% of women during the perinatal period [1]. Sertraline, a selective serotonin reuptake inhibitor, is one…

Read more

A pharmacokinetic-pharmacodynamic model characterizing antibiotic-induced morphological changes in Pseudomonas aeruginosa from time-lapse microscopy images

Thursday 16 October, 2025

Introduction: Pseudomonas aeruginosa are Gram-negative, rod-shaped bacilli that can cause a variety of infections, ranging from relatively non-severe urinary tract infections…

Read more

Amikacin dose optimization in the emergency department: A population pharmaco-kinetic simulation study

Thursday 16 October, 2025

Objectives:  Sepsis related to Gram-negative infections is a life-threatening organ dysfunction responsible for 11 million deaths per year worldwide [1]….

Read more

Model-informed comparison of the clinical relevance of four renal function markers on meropenem target attainment in critically ill septic patients

Thursday 16 October, 2025

Introduction :  Evaluation of the renal function is important in critically ill septic patients, particularly for drugs like meropenem, that…

Read more

Physiologically Based Pharmacokinetic (PBPK) Modelling to Predict Human Milk Exposure to medicines: a contribution from the ConcePTION Project

Thursday 16 October, 2025

Objectives:  Breastfeeding is associated with positive health effects for mother and infant [1]. However, postpartum women often need medicines [2]….

Read more

Physiologically-Based Pharmacokinetic (PBPK) Modelling to Predict Human Milk Exposure to Sildenafil and Bosentan: a contribution from the ConcePTION Project

Thursday 16 October, 2025

Objectives: Sildenafil and bosentan are used as combined therapy for pulmonary arterial hypertension (PAH). Since pregnancy is contra-indicated for women…

Read more

The comparison of pharmacoeconomic and pharmacometric modelling to improve cost-effectiveness assessment of sunitinib in GIST.

Thursday 16 October, 2025

Objectives:  Governmental organisations are continuously making difficult decisions regarding regulatory approval, balancing drug efficacy against toxicity and costs. Pharmacoeconomic (PE)…

Read more

A Population Pharmacokinetic Model for Creatinine with and without ingestion of cooked meat

Thursday 16 October, 2025

Introduction: Estimated glomerular filtration rate (GFR) based on serum creatinine is now widely reported by clinical laboratories, and in most…

Read more

Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in patients with external ventricular drain

Thursday 16 October, 2025

Introduction: Vancomycin is a standard therapy for central nervous system (CNS) infections, specifically nosocomial infections, caused by Gram-positive penicillin-resistant pathogens…

Read more

Physiologically Based Pharmacokinetic Modeling of a CYP3A4-Mediated Drug-Drug Interaction: Prediction of Victim of Induction, not Inhibition, with a Moderate Fraction Metabolized by CYP3A4

Thursday 16 October, 2025

Introduction: As part of the clinical development plan, a set of in vitro studies were undertaken to determine the drug-drug…

Read more